The brain’s intractable nature makes neurodegenerative disorders challenging to study, but modern assays and technologies give scientists a fresh look at this complex organ. In this episode, Niki Spahich from The Scientist’s Creative Services Team spoke with Erdem Gültekin Tamgüney, a professor in the Institute of Physical Biology at Heinrich Heine University, Düsseldorf, about technologies driving modern neuroscience research and his own work exploring the link between ischemic stroke and Parkinson’s disease.
LabTalk is a special edition podcast produced by The Scientist‘s Creative Services Team, where we explore topics at the leading edge of innovative research. This month’s episode is sponsored by PerkinElmer.
Erdem Gültekin Tamgüney, PhD
Institute of Physical Biology
Heinrich Heine University, Düsseldorf
PerkinElmer is a leading provider of end-to-end solutions that help scientists, researchers, and clinicians better diagnose disease and discover new and more personalized drugs. They deliver solutions that accelerate workflows, provide actionable insights, and support improved decision making.